Expands Response Biomedical beyond acute care into chronic disease and wellness testingIntroduces a next-generation platform for metabolic and ...
VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), ...
BOULDER, Colo.--(BUSINESS WIRE)--Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the launch of SHORTEN-ctDNA, a clinical trial ...
PLEASANT GROVE, Utah, Jan. 29, 2026 /PRNewswire/ -- Renew Biotechnologies (Renew) today announced its role as the clinical testing provider for Path Fertility's NOA Guide, a newly launched epigenetic ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Test is supported by peer-reviewed research published in Molecular Psychiatry, a Nature portfolio journal The MDM Gut & Brain Health Test measures a proprietary panel of microbially derived ...
BCAL Diagnostics Limited (AU:BDX) has released an update. BCAL Diagnostics Limited is set to launch the first phase of its BREASTEST product commercially at the Sydney Breast Clinic in early 2025, ...
More Diagnostics, a trusted leader in in vitro diagnostic quality controls for over 30 years, is proud to announce the debut of two advanced cardiac-focused products: a High-Sensitivity Troponin ...
BCAL Diagnostics Limited (AU:BDX) has released an update. BCAL Diagnostics Limited is gearing up for the commercial launch of their breast cancer detection tool, BREASTEST®, with a new commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results